TNFerade™ represents a novel approach to treating cancer in combination with radiation and/or chemotherapy by introducing tumor necrosis factor-alpha (TNF-alpha), a potent anti-cancer protein, directly into tumors. TNFerade has been evaluated for its potential use in indications such as pancreatic cancer, head and neck cancer, esophageal cancer, and rectal cancer.